APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Self-replicating mRNA Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Self-replicating mRNA Vaccines Market Analysis and Forecast 2026-2032

Report ID 174034600227 December 2025196 pages

Choose your research edition.

Industry ResearchSelf-replicating mRNA Vaccines Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Self-replicating mRNA Vaccines Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Self-replicating mRNA Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Self-replicating mRNA Vaccines Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Self-replicating mRNA Vaccines Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Self-replicating mRNA Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Self-replicating mRNA Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Self-replicating mRNA Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Self-replicating mRNA Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Self-replicating mRNA Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Self-replicating mRNA Vaccines include Aldevron, Arcturus Therapeutics, BioNTech, Chimeron Bio, CSL, Elixirgen Therapeutics, Gritstone Bio, Precision Nanosystems and Replicate Bioscience, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Self-replicating mRNA Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Self-replicating mRNA Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Self-replicating mRNA Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Self-replicating mRNA Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Self-replicating mRNA Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Self-replicating mRNA Vaccines sales, projected growth trends, production technology, application and end-user industry.

Self-replicating mRNA Vaccines Segment by Company

Aldevron

Arcturus Therapeutics

BioNTech

Chimeron Bio

CSL

Elixirgen Therapeutics

Gritstone Bio

Precision Nanosystems

Replicate Bioscience

VaxEquity

Ziphius Vaccines

GSK

Immorna

Self-replicating mRNA Vaccines Segment by Type

Preventive Medicine

Medicine

Self-replicating mRNA Vaccines Segment by Application

Infectious Disease

Cancer

Others

Self-replicating mRNA Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Self-replicating mRNA Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Self-replicating mRNA Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Self-replicating mRNA Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Self-replicating mRNA Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Self-replicating mRNA Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Self-replicating mRNA Vaccines sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Self-replicating mRNA Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Preventive Medicine Major Manufacturers Table 3. Medicine Major Manufacturers Table 4. Global Self-replicating mRNA Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Infectious Disease Major Manufacturers Table 6. Cancer Major Manufacturers Table 7. Others Major Manufacturers Table 8. Self-replicating mRNA Vaccines Industry Trends Table 9. Self-replicating mRNA Vaccines Industry Drivers Table 10. Self-replicating mRNA Vaccines Industry Opportunities and Challenges Table 11. Self-replicating mRNA Vaccines Industry Restraints Table 12. Global Self-replicating mRNA Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Self-replicating mRNA Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Self-replicating mRNA Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Self-replicating mRNA Vaccines Revenue Market Share by Region (2021-2026) Table 16. Global Self-replicating mRNA Vaccines Revenue Market Share by Region (2027-2032) Table 17. Global Self-replicating mRNA Vaccines Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Self-replicating mRNA Vaccines Sales by Region (2021-2026) & (K Units) Table 19. Global Self-replicating mRNA Vaccines Sales by Region (2027-2032) & (K Units) Table 20. Global Self-replicating mRNA Vaccines Sales Market Share by Region (2021-2026) Table 21. Global Self-replicating mRNA Vaccines Sales Market Share by Region (2027-2032) Table 22. Global Self-replicating mRNA Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Self-replicating mRNA Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Self-replicating mRNA Vaccines Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Self-replicating mRNA Vaccines Sales Market Share by Manufacturers (2021-2026) Table 26. Global Self-replicating mRNA Vaccines Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Self-replicating mRNA Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Self-replicating mRNA Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Self-replicating mRNA Vaccines Manufacturers, Product Type & Application Table 30. Global Self-replicating mRNA Vaccines Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Self-replicating mRNA Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Self-replicating mRNA Vaccines Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Self-replicating mRNA Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Self-replicating mRNA Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Self-replicating mRNA Vaccines Revenue Market Share by Type (2021-2026) Table 37. Global Self-replicating mRNA Vaccines Revenue Market Share by Type (2027-2032) Table 38. Global Self-replicating mRNA Vaccines Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Self-replicating mRNA Vaccines Sales by Type (2021-2026) & (K Units) Table 40. Global Self-replicating mRNA Vaccines Sales by Type (2027-2032) & (K Units) Table 41. Global Self-replicating mRNA Vaccines Sales Market Share by Type (2021-2026) Table 42. Global Self-replicating mRNA Vaccines Sales Market Share by Type (2027-2032) Table 43. Global Self-replicating mRNA Vaccines Price by Type (2021-2026) & (US$/Unit) Table 44. Global Self-replicating mRNA Vaccines Price by Type (2027-2032) & (US$/Unit) Table 45. Global Self-replicating mRNA Vaccines Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Self-replicating mRNA Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Self-replicating mRNA Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Self-replicating mRNA Vaccines Revenue Market Share by Application (2021-2026) Table 49. Global Self-replicating mRNA Vaccines Revenue Market Share by Application (2027-2032) Table 50. Global Self-replicating mRNA Vaccines Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Self-replicating mRNA Vaccines Sales by Application (2021-2026) & (K Units) Table 52. Global Self-replicating mRNA Vaccines Sales by Application (2027-2032) & (K Units) Table 53. Global Self-replicating mRNA Vaccines Sales Market Share by Application (2021-2026) Table 54. Global Self-replicating mRNA Vaccines Sales Market Share by Application (2027-2032) Table 55. Global Self-replicating mRNA Vaccines Price by Application (2021-2026) & (US$/Unit) Table 56. Global Self-replicating mRNA Vaccines Price by Application (2027-2032) & (US$/Unit) Table 57. Aldevron Company Information Table 58. Aldevron Business Overview Table 59. Aldevron Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Aldevron Self-replicating mRNA Vaccines Product Portfolio Table 61. Aldevron Recent Development Table 62. Arcturus Therapeutics Company Information Table 63. Arcturus Therapeutics Business Overview Table 64. Arcturus Therapeutics Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Arcturus Therapeutics Self-replicating mRNA Vaccines Product Portfolio Table 66. Arcturus Therapeutics Recent Development Table 67. BioNTech Company Information Table 68. BioNTech Business Overview Table 69. BioNTech Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. BioNTech Self-replicating mRNA Vaccines Product Portfolio Table 71. BioNTech Recent Development Table 72. Chimeron Bio Company Information Table 73. Chimeron Bio Business Overview Table 74. Chimeron Bio Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Chimeron Bio Self-replicating mRNA Vaccines Product Portfolio Table 76. Chimeron Bio Recent Development Table 77. CSL Company Information Table 78. CSL Business Overview Table 79. CSL Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. CSL Self-replicating mRNA Vaccines Product Portfolio Table 81. CSL Recent Development Table 82. Elixirgen Therapeutics Company Information Table 83. Elixirgen Therapeutics Business Overview Table 84. Elixirgen Therapeutics Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Elixirgen Therapeutics Self-replicating mRNA Vaccines Product Portfolio Table 86. Elixirgen Therapeutics Recent Development Table 87. Gritstone Bio Company Information Table 88. Gritstone Bio Business Overview Table 89. Gritstone Bio Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Gritstone Bio Self-replicating mRNA Vaccines Product Portfolio Table 91. Gritstone Bio Recent Development Table 92. Precision Nanosystems Company Information Table 93. Precision Nanosystems Business Overview Table 94. Precision Nanosystems Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Precision Nanosystems Self-replicating mRNA Vaccines Product Portfolio Table 96. Precision Nanosystems Recent Development Table 97. Replicate Bioscience Company Information Table 98. Replicate Bioscience Business Overview Table 99. Replicate Bioscience Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Replicate Bioscience Self-replicating mRNA Vaccines Product Portfolio Table 101. Replicate Bioscience Recent Development Table 102. VaxEquity Company Information Table 103. VaxEquity Business Overview Table 104. VaxEquity Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. VaxEquity Self-replicating mRNA Vaccines Product Portfolio Table 106. VaxEquity Recent Development Table 107. Ziphius Vaccines Company Information Table 108. Ziphius Vaccines Business Overview Table 109. Ziphius Vaccines Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Ziphius Vaccines Self-replicating mRNA Vaccines Product Portfolio Table 111. Ziphius Vaccines Recent Development Table 112. GSK Company Information Table 113. GSK Business Overview Table 114. GSK Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. GSK Self-replicating mRNA Vaccines Product Portfolio Table 116. GSK Recent Development Table 117. Immorna Company Information Table 118. Immorna Business Overview Table 119. Immorna Self-replicating mRNA Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Immorna Self-replicating mRNA Vaccines Product Portfolio Table 121. Immorna Recent Development Table 122. North America Self-replicating mRNA Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 123. North America Self-replicating mRNA Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 124. North America Self-replicating mRNA Vaccines Sales by Type (2021-2026) & (K Units) Table 125. North America Self-replicating mRNA Vaccines Sales by Type (2027-2032) & (K Units) Table 126. North America Self-replicating mRNA Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 127. North America Self-replicating mRNA Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 128. North America Self-replicating mRNA Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 129. North America Self-replicating mRNA Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 130. North America Self-replicating mRNA Vaccines Sales by Application (2021-2026) & (K Units) Table 131. North America Self-replicating mRNA Vaccines Sales by Application (2027-2032) & (K Units) Table 132. North America Self-replicating mRNA Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 133. North America Self-replicating mRNA Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 134. North America Self-replicating mRNA Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. North America Self-replicating mRNA Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 136. North America Self-replicating mRNA Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 137. North America Self-replicating mRNA Vaccines Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 138. North America Self-replicating mRNA Vaccines Sales by Country (2021-2026) & (K Units) Table 139. North America Self-replicating mRNA Vaccines Sales by Country (2027-2032) & (K Units) Table 140. North America Self-replicating mRNA Vaccines Sales Price by Country (2021-2026) & (US$/Unit) Table 141. North America Self-replicating mRNA Vaccines Sales Price by Country (2027-2032) & (US$/Unit) Table 142. United States Self-replicating mRNA Vaccines Revenue (2021-2032) & (US$ Million) Table 143. Canada Self-replicating mRNA Vaccines Revenue (2021-2032) & (US$ Million) Table 144. Mexico Self-replicating mRNA Vaccines Revenue (2021-2032) & (US$ Million) Table 145. Europe Self-replicating mRNA Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 146. Europe Self-replicating mRNA Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 147. Europe Self-replicating mRNA Vaccines Sales by Type (2021-2026) & (K Units) Table 148. Europe Self-replicating mRNA Vaccines Sales by Type (2027-2032) & (K Units) Table 149. Europe Self-replicating mRNA Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 150. Europe Self-replicating mRNA Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 151. Europe Self-replicating mRNA Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 152. Europe Self-replicating mRNA Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 153. Europe Self-replicating mRNA Vaccines Sales by Application (2021-2026) & (K Units) Table 154. Europe Self-replicating mRNA Vaccines Sales by Application (2027-2032) & (K Units) Table 155. Europe Self-replicating mRNA Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 156. Europe Self-replicating mRNA Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 157. Europe Self-replicating mRNA Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 158. Europe Self-replicating mRNA Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 159. Europe Self-replicating mRNA Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 160. Europe Self-replicating mRNA Vaccines Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 161. Europe Self-replicating mRNA Vaccines Sales by Country (2021-2026) & (K Units) Table 162. Europe Self-replicating mRNA Vaccines Sales by Country (2027-2032) & (K Units) Table 163. Europe Self-replicating mRNA Vaccines Sales Price by Country (2021-2026) & (US$/Unit) Table 164. Europe Self-replicating mRNA Vaccines Sales Price by Country (2027-2032) & (US$/Unit) Table 165. Germany Self-replicating mRNA Vaccines Revenue (2021-2032) & (US$ Million) Table 166. France Self-replicating mRNA Vaccines Revenue (2021-2032) & (US$ Million) Table 167. U.K. Self-replicating mRNA Vaccines Revenue (2021-2032) & (US$ Million) Table 168. Italy Self-replicating mRNA Vaccines Revenue (2021-2032) & (US$ Million) Table 169. Russia Self-replicating mRNA Vaccines Revenue (2021-2032) & (US$ Million) Table 170. Spain Self-replicating mRNA Vaccines Revenue (2021-2032) & (US$ Million) Table 171. Netherlands Self-replicating mRNA Vaccines Revenue (2021-2032) & (US$ Million) Table 172. Switzerland Self-replicating mRNA Vaccines Revenue (2021-2032) & (US$ Million) Table 173. Sweden Self-replicating mRNA Vaccines Revenue (2021-2032) & (US$ Million) Table 174. Poland Self-replicating mRNA Vaccines Revenue (2021-2032) & (US$ Million) Table 175. China Self-replicating mRNA Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 176. China Self-replicating mRNA Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 177. China Self-replicating mRNA Vaccines Sales by Type (2021-2026) & (K Units) Table 178. China Self-replicating mRNA Vaccines Sales by Type (2027-2032) & (K Units) Table 179. China Self-replicating mRNA Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 180. China Self-replicating mRNA Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 181. China Self-replicating mRNA Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 182. China Self-replicating mRNA Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 183. China Self-replicating mRNA Vaccines Sales by Application (2021-2026) & (K Units) Table 184. China Self-replicating mRNA Vaccines Sales by Application (2027-2032) & (K Units) Table 185. China Self-replicating mRNA Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 186. China Self-replicating mRNA Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 187. Asia Self-replicating mRNA Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 188. Asia Self-replicating mRNA Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 189. Asia Self-replicating mRNA Vaccines Sales by Type (2021-2026) & (K Units) Table 190. Asia Self-replicating mRNA Vaccines Sales by Type (2027-2032) & (K Units) Table 191. Asia Self-replicating mRNA Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 192. Asia Self-replicating mRNA Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 193. Asia Self-replicating mRNA Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 194. Asia Self-replicating mRNA Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 195. Asia Self-replicating mRNA Vaccines Sales by Application (2021-2026) & (K Units) Table 196. Asia Self-replicating mRNA Vaccines Sales by Application (2027-2032) & (K Units) Table 197. Asia Self-replicating mRNA Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 198. Asia Self-replicating mRNA Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 199. Asia Self-replicating mRNA Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 200. Asia Self-replicating mRNA Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 201. Asia Self-replicating mRNA Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 202. Asia Self-replicating mRNA Vaccines Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 203. Asia Self-replicating mRNA Vaccines Sales by Country (2021-2026) & (K Units) Table 204. Asia Self-replicating mRNA Vaccines Sales by Country (2027-2032) & (K Units) Table 205. Asia Self-replicating mRNA Vaccines Sales Price by Country (2021-2026) & (US$/Unit) Table 206. Asia Self-replicating mRNA Vaccines Sales Price by Country (2027-2032) & (US$/Unit) Table 207. Japan Self-replicating mRNA Vaccines Revenue (2021-2032) & (US$ Million) Table 208. South Korea Self-replicating mRNA Vaccines Revenue (2021-2032) & (US$ Million) Table 209. India Self-replicating mRNA Vaccines Revenue (2021-2032) & (US$ Million) Table 210. Australia Self-replicating mRNA Vaccines Revenue (2021-2032) & (US$ Million) Table 211. Taiwan Self-replicating mRNA Vaccines Revenue (2021-2032) & (US$ Million) Table 212. Southeast Asia Self-replicating mRNA Vaccines Revenue (2021-2032) & (US$ Million) Table 213. SAMEA Self-replicating mRNA Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 214. SAMEA Self-replicating mRNA Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 215. SAMEA Self-replicating mRNA Vaccines Sales by Type (2021-2026) & (K Units) Table 216. SAMEA Self-replicating mRNA Vaccines Sales by Type (2027-2032) & (K Units) Table 217. SAMEA Self-replicating mRNA Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 218. SAMEA Self-replicating mRNA Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 219. SAMEA Self-replicating mRNA Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 220. SAMEA Self-replicating mRNA Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 221. SAMEA Self-replicating mRNA Vaccines Sales by Application (2021-2026) & (K Units) Table 222. SAMEA Self-replicating mRNA Vaccines Sales by Application (2027-2032) & (K Units) Table 223. SAMEA Self-replicating mRNA Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 224. SAMEA Self-replicating mRNA Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 225. SAMEA Self-replicating mRNA Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 226. SAMEA Self-replicating mRNA Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 227. SAMEA Self-replicating mRNA Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 228. SAMEA Self-replicating mRNA Vaccines Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 229. SAMEA Self-replicating mRNA Vaccines Sales by Country (2021-2026) & (K Units) Table 230. SAMEA Self-replicating mRNA Vaccines Sales by Country (2027-2032) & (K Units) Table 231. SAMEA Self-replicating mRNA Vaccines Sales Price by Country (2021-2026) & (US$/Unit) Table 232. SAMEA Self-replicating mRNA Vaccines Sales Price by Country (2027-2032) & (US$/Unit) Table 233. Brazil Self-replicating mRNA Vaccines Revenue (2021-2032) & (US$ Million) Table 234. Argentina Self-replicating mRNA Vaccines Revenue (2021-2032) & (US$ Million) Table 235. Chile Self-replicating mRNA Vaccines Revenue (2021-2032) & (US$ Million) Table 236. Colombia Self-replicating mRNA Vaccines Revenue (2021-2032) & (US$ Million) Table 237. Peru Self-replicating mRNA Vaccines Revenue (2021-2032) & (US$ Million) Table 238. Saudi Arabia Self-replicating mRNA Vaccines Revenue (2021-2032) & (US$ Million) Table 239. Israel Self-replicating mRNA Vaccines Revenue (2021-2032) & (US$ Million) Table 240. UAE Self-replicating mRNA Vaccines Revenue (2021-2032) & (US$ Million) Table 241. Turkey Self-replicating mRNA Vaccines Revenue (2021-2032) & (US$ Million) Table 242. Iran Self-replicating mRNA Vaccines Revenue (2021-2032) & (US$ Million) Table 243. Egypt Self-replicating mRNA Vaccines Revenue (2021-2032) & (US$ Million) Table 244. Key Raw Materials Table 245. Raw Materials Key Suppliers Table 246. Self-replicating mRNA Vaccines Distributors List Table 247. Self-replicating mRNA Vaccines Customers List Table 248. Research Programs/Design for This Report Table 249. Authors List of This Report Table 250. Secondary Sources Table 251. Primary Sources List of Figures Figure 1. Self-replicating mRNA Vaccines Image Figure 2. Global Self-replicating mRNA Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Self-replicating mRNA Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 4. Preventive Medicine Image Figure 5. Medicine Image Figure 6. Global Self-replicating mRNA Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Self-replicating mRNA Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 8. Infectious Disease Image Figure 9. Cancer Image Figure 10. Others Image Figure 11. Global Self-replicating mRNA Vaccines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Self-replicating mRNA Vaccines Revenue (2021-2032) & (US$ Million) Figure 13. Global Self-replicating mRNA Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Self-replicating mRNA Vaccines Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Self-replicating mRNA Vaccines Revenue Market Share by Region (2021-2032) Figure 16. Global Self-replicating mRNA Vaccines Sales (2021-2032) & (K Units) Figure 17. Global Self-replicating mRNA Vaccines Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Self-replicating mRNA Vaccines Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Self-replicating mRNA Vaccines Sales YoY (2021-2032) & (K Units) Figure 20. Europe Self-replicating mRNA Vaccines Sales YoY (2021-2032) & (K Units) Figure 21. China Self-replicating mRNA Vaccines Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Self-replicating mRNA Vaccines Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Self-replicating mRNA Vaccines Sales YoY (2021-2032) & (K Units) Figure 24. Global Self-replicating mRNA Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Self-replicating mRNA Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Self-replicating mRNA Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Self-replicating mRNA Vaccines Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Self-replicating mRNA Vaccines Revenue Market Share by Type (2021-2032) Figure 30. Global Self-replicating mRNA Vaccines Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Self-replicating mRNA Vaccines Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Self-replicating mRNA Vaccines Sales Market Share by Type (2021-2032) Figure 33. Global Self-replicating mRNA Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Self-replicating mRNA Vaccines Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Self-replicating mRNA Vaccines Revenue Market Share by Application (2021-2032) Figure 36. Global Self-replicating mRNA Vaccines Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Self-replicating mRNA Vaccines Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Self-replicating mRNA Vaccines Sales Market Share by Application (2021-2032) Figure 39. North America Self-replicating mRNA Vaccines Revenue Share by Type (2021-2032) Figure 40. North America Self-replicating mRNA Vaccines Sales Share by Type (2021-2032) Figure 41. North America Self-replicating mRNA Vaccines Revenue Share by Application (2021-2032) Figure 42. North America Self-replicating mRNA Vaccines Sales Share by Application (2021-2032) Figure 43. North America Self-replicating mRNA Vaccines Revenue Share by Country (2021-2032) Figure 44. North America Self-replicating mRNA Vaccines Sales Share by Country (2021-2032) Figure 45. Europe Self-replicating mRNA Vaccines Revenue Share by Type (2021-2032) Figure 46. Europe Self-replicating mRNA Vaccines Sales Share by Type (2021-2032) Figure 47. Europe Self-replicating mRNA Vaccines Revenue Share by Application (2021-2032) Figure 48. Europe Self-replicating mRNA Vaccines Sales Share by Application (2021-2032) Figure 49. Europe Self-replicating mRNA Vaccines Revenue Share by Country (2021-2032) Figure 50. Europe Self-replicating mRNA Vaccines Sales Share by Country (2021-2032) Figure 51. China Self-replicating mRNA Vaccines Revenue Share by Type (2021-2032) Figure 52. China Self-replicating mRNA Vaccines Sales Share by Type (2021-2032) Figure 53. China Self-replicating mRNA Vaccines Revenue Share by Application (2021-2032) Figure 54. China Self-replicating mRNA Vaccines Sales Share by Application (2021-2032) Figure 55. Asia Self-replicating mRNA Vaccines Revenue Share by Type (2021-2032) Figure 56. Asia Self-replicating mRNA Vaccines Sales Share by Type (2021-2032) Figure 57. Asia Self-replicating mRNA Vaccines Revenue Share by Application (2021-2032) Figure 58. Asia Self-replicating mRNA Vaccines Sales Share by Application (2021-2032) Figure 59. Asia Self-replicating mRNA Vaccines Revenue Share by Country (2021-2032) Figure 60. Asia Self-replicating mRNA Vaccines Sales Share by Country (2021-2032) Figure 61. SAMEA Self-replicating mRNA Vaccines Revenue Share by Type (2021-2032) Figure 62. SAMEA Self-replicating mRNA Vaccines Sales Share by Type (2021-2032) Figure 63. SAMEA Self-replicating mRNA Vaccines Revenue Share by Application (2021-2032) Figure 64. SAMEA Self-replicating mRNA Vaccines Sales Share by Application (2021-2032) Figure 65. SAMEA Self-replicating mRNA Vaccines Revenue Share by Country (2021-2032) Figure 66. SAMEA Self-replicating mRNA Vaccines Sales Share by Country (2021-2032) Figure 67. Self-replicating mRNA Vaccines Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Self-replicating mRNA Vaccines Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Preventive Medicine
  • Medicine
Applications
  • Infectious Disease
  • Cancer
  • Others
Companies covered
  • Aldevron
  • Arcturus Therapeutics
  • BioNTech
  • Chimeron Bio
  • CSL
  • Elixirgen Therapeutics
  • Gritstone Bio
  • Precision Nanosystems
  • Replicate Bioscience
  • VaxEquity
  • Ziphius Vaccines
  • GSK
  • Immorna

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Self-replicating mRNA Vaccines Market by Type
  3. 1.2.1 Global Self-replicating mRNA Vaccines Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Preventive Medicine
  5. 1.2.3 Medicine
  6. 1.3 Self-replicating mRNA Vaccines Market by Application
  7. 1.3.1 Global Self-replicating mRNA Vaccines Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Infectious Disease
  9. 1.3.3 Cancer
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Self-replicating mRNA Vaccines Market Dynamics
  1. 2.1 Self-replicating mRNA Vaccines Industry Trends
  2. 2.2 Self-replicating mRNA Vaccines Industry Drivers
  3. 2.3 Self-replicating mRNA Vaccines Industry Opportunities and Challenges
  4. 2.4 Self-replicating mRNA Vaccines Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Self-replicating mRNA Vaccines Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Self-replicating mRNA Vaccines Revenue by Region
  3. 3.2.1 Global Self-replicating mRNA Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Self-replicating mRNA Vaccines Revenue by Region (2021-2026)
  5. 3.2.3 Global Self-replicating mRNA Vaccines Revenue by Region (2027-2032)
  6. 3.2.4 Global Self-replicating mRNA Vaccines Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Self-replicating mRNA Vaccines Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Self-replicating mRNA Vaccines Sales by Region
  9. 3.4.1 Global Self-replicating mRNA Vaccines Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Self-replicating mRNA Vaccines Sales by Region (2021-2026)
  11. 3.4.3 Global Self-replicating mRNA Vaccines Sales by Region (2027-2032)
  12. 3.4.4 Global Self-replicating mRNA Vaccines Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Self-replicating mRNA Vaccines Revenue by Manufacturers
  2. 4.1.1 Global Self-replicating mRNA Vaccines Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Self-replicating mRNA Vaccines Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Self-replicating mRNA Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Self-replicating mRNA Vaccines Sales by Manufacturers
  6. 4.2.1 Global Self-replicating mRNA Vaccines Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Self-replicating mRNA Vaccines Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Self-replicating mRNA Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Self-replicating mRNA Vaccines Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Self-replicating mRNA Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Self-replicating mRNA Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Self-replicating mRNA Vaccines Manufacturers, Product Type & Application
  13. 4.7 Global Self-replicating mRNA Vaccines Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Self-replicating mRNA Vaccines Market CR5 and HHI
  16. 4.8.2 2025 Self-replicating mRNA Vaccines Tier 1, Tier 2, and Tier 3
5 Self-replicating mRNA Vaccines Market by Type
  1. 5.1 Global Self-replicating mRNA Vaccines Revenue by Type
  2. 5.1.1 Global Self-replicating mRNA Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Self-replicating mRNA Vaccines Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Self-replicating mRNA Vaccines Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Self-replicating mRNA Vaccines Sales by Type
  6. 5.2.1 Global Self-replicating mRNA Vaccines Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Self-replicating mRNA Vaccines Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Self-replicating mRNA Vaccines Sales Market Share by Type (2021-2032)
  9. 5.3 Global Self-replicating mRNA Vaccines Price by Type
6 Self-replicating mRNA Vaccines Market by Application
  1. 6.1 Global Self-replicating mRNA Vaccines Revenue by Application
  2. 6.1.1 Global Self-replicating mRNA Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Self-replicating mRNA Vaccines Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Self-replicating mRNA Vaccines Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Self-replicating mRNA Vaccines Sales by Application
  6. 6.2.1 Global Self-replicating mRNA Vaccines Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Self-replicating mRNA Vaccines Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Self-replicating mRNA Vaccines Sales Market Share by Application (2021-2032)
  9. 6.3 Global Self-replicating mRNA Vaccines Price by Application
7 Company Profiles
  1. 7.1 Aldevron
  2. 7.1.1 Aldevron Company Information
  3. 7.1.2 Aldevron Business Overview
  4. 7.1.3 Aldevron Self-replicating mRNA Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Aldevron Self-replicating mRNA Vaccines Product Portfolio
  6. 7.1.5 Aldevron Recent Developments
  7. 7.2 Arcturus Therapeutics
  8. 7.2.1 Arcturus Therapeutics Company Information
  9. 7.2.2 Arcturus Therapeutics Business Overview
  10. 7.2.3 Arcturus Therapeutics Self-replicating mRNA Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Arcturus Therapeutics Self-replicating mRNA Vaccines Product Portfolio
  12. 7.2.5 Arcturus Therapeutics Recent Developments
  13. 7.3 BioNTech
  14. 7.3.1 BioNTech Company Information
  15. 7.3.2 BioNTech Business Overview
  16. 7.3.3 BioNTech Self-replicating mRNA Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 BioNTech Self-replicating mRNA Vaccines Product Portfolio
  18. 7.3.5 BioNTech Recent Developments
  19. 7.4 Chimeron Bio
  20. 7.4.1 Chimeron Bio Company Information
  21. 7.4.2 Chimeron Bio Business Overview
  22. 7.4.3 Chimeron Bio Self-replicating mRNA Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Chimeron Bio Self-replicating mRNA Vaccines Product Portfolio
  24. 7.4.5 Chimeron Bio Recent Developments
  25. 7.5 CSL
  26. 7.5.1 CSL Company Information
  27. 7.5.2 CSL Business Overview
  28. 7.5.3 CSL Self-replicating mRNA Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 CSL Self-replicating mRNA Vaccines Product Portfolio
  30. 7.5.5 CSL Recent Developments
  31. 7.6 Elixirgen Therapeutics
  32. 7.6.1 Elixirgen Therapeutics Company Information
  33. 7.6.2 Elixirgen Therapeutics Business Overview
  34. 7.6.3 Elixirgen Therapeutics Self-replicating mRNA Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Elixirgen Therapeutics Self-replicating mRNA Vaccines Product Portfolio
  36. 7.6.5 Elixirgen Therapeutics Recent Developments
  37. 7.7 Gritstone Bio
  38. 7.7.1 Gritstone Bio Company Information
  39. 7.7.2 Gritstone Bio Business Overview
  40. 7.7.3 Gritstone Bio Self-replicating mRNA Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Gritstone Bio Self-replicating mRNA Vaccines Product Portfolio
  42. 7.7.5 Gritstone Bio Recent Developments
  43. 7.8 Precision Nanosystems
  44. 7.8.1 Precision Nanosystems Company Information
  45. 7.8.2 Precision Nanosystems Business Overview
  46. 7.8.3 Precision Nanosystems Self-replicating mRNA Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Precision Nanosystems Self-replicating mRNA Vaccines Product Portfolio
  48. 7.8.5 Precision Nanosystems Recent Developments
  49. 7.9 Replicate Bioscience
  50. 7.9.1 Replicate Bioscience Company Information
  51. 7.9.2 Replicate Bioscience Business Overview
  52. 7.9.3 Replicate Bioscience Self-replicating mRNA Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Replicate Bioscience Self-replicating mRNA Vaccines Product Portfolio
  54. 7.9.5 Replicate Bioscience Recent Developments
  55. 7.10 VaxEquity
  56. 7.10.1 VaxEquity Company Information
  57. 7.10.2 VaxEquity Business Overview
  58. 7.10.3 VaxEquity Self-replicating mRNA Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 VaxEquity Self-replicating mRNA Vaccines Product Portfolio
  60. 7.10.5 VaxEquity Recent Developments
  61. 7.11 Ziphius Vaccines
  62. 7.11.1 Ziphius Vaccines Company Information
  63. 7.11.2 Ziphius Vaccines Business Overview
  64. 7.11.3 Ziphius Vaccines Self-replicating mRNA Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Ziphius Vaccines Self-replicating mRNA Vaccines Product Portfolio
  66. 7.11.5 Ziphius Vaccines Recent Developments
  67. 7.12 GSK
  68. 7.12.1 GSK Company Information
  69. 7.12.2 GSK Business Overview
  70. 7.12.3 GSK Self-replicating mRNA Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 GSK Self-replicating mRNA Vaccines Product Portfolio
  72. 7.12.5 GSK Recent Developments
  73. 7.13 Immorna
  74. 7.13.1 Immorna Company Information
  75. 7.13.2 Immorna Business Overview
  76. 7.13.3 Immorna Self-replicating mRNA Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Immorna Self-replicating mRNA Vaccines Product Portfolio
  78. 7.13.5 Immorna Recent Developments
8 North America
  1. 8.1 North America Self-replicating mRNA Vaccines Market Size by Type
  2. 8.1.1 North America Self-replicating mRNA Vaccines Revenue by Type (2021-2032)
  3. 8.1.2 North America Self-replicating mRNA Vaccines Sales by Type (2021-2032)
  4. 8.1.3 North America Self-replicating mRNA Vaccines Price by Type (2021-2032)
  5. 8.2 North America Self-replicating mRNA Vaccines Market Size by Application
  6. 8.2.1 North America Self-replicating mRNA Vaccines Revenue by Application (2021-2032)
  7. 8.2.2 North America Self-replicating mRNA Vaccines Sales by Application (2021-2032)
  8. 8.2.3 North America Self-replicating mRNA Vaccines Price by Application (2021-2032)
  9. 8.3 North America Self-replicating mRNA Vaccines Market Size by Country
  10. 8.3.1 North America Self-replicating mRNA Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Self-replicating mRNA Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Self-replicating mRNA Vaccines Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Self-replicating mRNA Vaccines Market Size by Type
  2. 9.1.1 Europe Self-replicating mRNA Vaccines Revenue by Type (2021-2032)
  3. 9.1.2 Europe Self-replicating mRNA Vaccines Sales by Type (2021-2032)
  4. 9.1.3 Europe Self-replicating mRNA Vaccines Price by Type (2021-2032)
  5. 9.2 Europe Self-replicating mRNA Vaccines Market Size by Application
  6. 9.2.1 Europe Self-replicating mRNA Vaccines Revenue by Application (2021-2032)
  7. 9.2.2 Europe Self-replicating mRNA Vaccines Sales by Application (2021-2032)
  8. 9.2.3 Europe Self-replicating mRNA Vaccines Price by Application (2021-2032)
  9. 9.3 Europe Self-replicating mRNA Vaccines Market Size by Country
  10. 9.3.1 Europe Self-replicating mRNA Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Self-replicating mRNA Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Self-replicating mRNA Vaccines Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Self-replicating mRNA Vaccines Market Size by Type
  2. 10.1.1 China Self-replicating mRNA Vaccines Revenue by Type (2021-2032)
  3. 10.1.2 China Self-replicating mRNA Vaccines Sales by Type (2021-2032)
  4. 10.1.3 China Self-replicating mRNA Vaccines Price by Type (2021-2032)
  5. 10.2 China Self-replicating mRNA Vaccines Market Size by Application
  6. 10.2.1 China Self-replicating mRNA Vaccines Revenue by Application (2021-2032)
  7. 10.2.2 China Self-replicating mRNA Vaccines Sales by Application (2021-2032)
  8. 10.2.3 China Self-replicating mRNA Vaccines Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Self-replicating mRNA Vaccines Market Size by Type
  2. 11.1.1 Asia Self-replicating mRNA Vaccines Revenue by Type (2021-2032)
  3. 11.1.2 Asia Self-replicating mRNA Vaccines Sales by Type (2021-2032)
  4. 11.1.3 Asia Self-replicating mRNA Vaccines Price by Type (2021-2032)
  5. 11.2 Asia Self-replicating mRNA Vaccines Market Size by Application
  6. 11.2.1 Asia Self-replicating mRNA Vaccines Revenue by Application (2021-2032)
  7. 11.2.2 Asia Self-replicating mRNA Vaccines Sales by Application (2021-2032)
  8. 11.2.3 Asia Self-replicating mRNA Vaccines Price by Application (2021-2032)
  9. 11.3 Asia Self-replicating mRNA Vaccines Market Size by Country
  10. 11.3.1 Asia Self-replicating mRNA Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Self-replicating mRNA Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Self-replicating mRNA Vaccines Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Self-replicating mRNA Vaccines Market Size by Type
  2. 12.1.1 SAMEA Self-replicating mRNA Vaccines Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Self-replicating mRNA Vaccines Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Self-replicating mRNA Vaccines Price by Type (2021-2032)
  5. 12.2 SAMEA Self-replicating mRNA Vaccines Market Size by Application
  6. 12.2.1 SAMEA Self-replicating mRNA Vaccines Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Self-replicating mRNA Vaccines Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Self-replicating mRNA Vaccines Price by Application (2021-2032)
  9. 12.3 SAMEA Self-replicating mRNA Vaccines Market Size by Country
  10. 12.3.1 SAMEA Self-replicating mRNA Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Self-replicating mRNA Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Self-replicating mRNA Vaccines Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Self-replicating mRNA Vaccines Value Chain Analysis
  2. 13.1.1 Self-replicating mRNA Vaccines Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Self-replicating mRNA Vaccines Production Mode & Process
  6. 13.2 Self-replicating mRNA Vaccines Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Self-replicating mRNA Vaccines Distributors
  9. 13.2.3 Self-replicating mRNA Vaccines Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst